top of page
ARTICLES
Subscribe to our Newsletter!
Subscribe to our newsletter for the latest in Biotech, Pharma, and Business.

Enjaymo Trades Hands Again: Antibodies and More
Sanofi is selling the global rights of Enjaymo, a treatment for cold agglutinin disease (CAD), a rare type of anemia in which red blood...
Nick Inboden
Oct 10, 20242 min read

BioAge Labs IPO: More Capital for Obesity Treatments
On Thursday of last week, BioAge Labs raised almost $200MM from their IPO. The company, with one therapeutic in a Phase 2 clinical trial...
Nick Inboden
Oct 3, 20242 min read

$1 Billion in Potential Capital For Protein Therapeutics
Novartis has signed a deal worth over $1 billion with Generate: Biomedicines. A computational biology company that uses machine learning...
Nick Inboden
Sep 26, 20242 min read

$700MM in One Day: The Latest in Biotech IPOs
IPOs from Bicari Therapeutics, Zenas BioPharma,and MBX Biosciences last Thursday raised a combined $700MM. With all companies focusing on...
Nick Inboden
Sep 19, 20243 min read

Roche's Innovation in Basel and the Weight Loss Market
Swiss multinational pharmaceutical giant Roche announced the opening of pRED Center Basel earlier today. The pRED Innovation Center Basel...
Nick Inboden
Sep 12, 20243 min read

The Biological Clock - Circadian Rhythm and Health
“Circadian Rhythm” is likely to make you think about your sleep cycle– you go to bed when it is dark, and you wake up when it is light....
Nick Inboden
Sep 5, 20243 min read

Unicorns and Rainbows: A Look at Two Biotech Startups Who Found Pots of Gold at The End of The Rainbow
Scrolling through LinkedIn, you might come across the term “Unicorn”. Not to be confused with the mythical horned creature, a unicorn is...
Nick Inboden
Aug 29, 20243 min read

The Guardian of the Genome: p53
The TP53 gene is a tumor suppressor gene responsible for producing the p53 protein found throughout the human body. The p53 protein is...
Nick Inboden
Aug 22, 20245 min read


Sugar and Sugar Alcohols - An Overview
If you see a food or beverage boasting about 0 grams of sugar and you turn over the item, on the nutritional label you will likely see...
Nick Inboden
Aug 15, 20245 min read


Biology and Beagles: The Evolution of Computational Biology
Computational biology, although not new, has made major leaps and gains in recent years. AlphaFold 2, created by Deepmind, a Google...
Nick Inboden
Aug 8, 20245 min read


Ibuprofen: The Metabolic Processes for Pain Relief
Ibuprofen, commonly known by its brand name Advil, is the most commonly used non-steroidal anti-inflammatory drug (NSAID) for both...
Nick Inboden
Aug 1, 20244 min read


Switzerland: A Powerhouse for Biotech and Finance
Though primarily known for political neutrality and financial privacy, Switzerland is also a powerhouse for biotechnology development and...
Nick Inboden
Jul 25, 20244 min read


Safeguarding Patient Privacy: Navigating AI Developments in Healthcare
As Artificial Intelligence (AI) continues to revolutionize healthcare, ensuring the protection of patient privacy has become a critical...
Nick Inboden
Jul 18, 20244 min read


Tailored Treatments: The Power of AI in Personalized Medicine
With advancements in modern medicine, “one-size-fits-all” treatment plans are quickly becoming outdated. As artificial intelligence (AI)...
Nick Inboden
Jul 11, 20245 min read


American Innovators: Pioneering Figures in Biotechnology and Medicine
With the largest economy in the world and a highly developed healthcare system, the United States has been a fertile ground for producing...
Nick Inboden
Jul 4, 20245 min read


Waves of Deception: The Broader Impact of Scientific Fraud
In recent years, scientific fraud has become an increasingly pressing concern within the research and startup communities. High-profile...
Nick Inboden
Jun 27, 20245 min read


Caffeine: The Science Behind Your Daily Boost
Caffeine is a ubiquitous stimulant that millions of people rely on daily to jump start their mornings, boost their productivity, and...
Nick Inboden
Jun 20, 20248 min read


The Price of Progress: Unpacking the High Cost of Drug Development
Taking a drug from discovery to market is no easy feat. The complexities involved in discovering possible drug candidates and navigating...
Nick Inboden
Jun 13, 20247 min read


Discovery to Deployment: The CRISPR Journey From Lab to Life-Changing Therapy
CRISPR technology has emerged as a revolutionary tool in science and medicine, capable of precisely altering DNA. With demonstrated...
Nick Inboden
Jun 6, 20247 min read


The Science Behind TAT: Precision, Power, and Promise
A cornerstone in the battle against cancer, radiotherapy encompasses a wide variety of techniques for the elimination of malignant cells....
Nick Inboden
May 30, 20245 min read


Wall Street's investments in AI - the future of Biotech and Medicine
With huge amounts of capital flowing into AI developments from Wall Street giants like Blackstone and JPMorgan Chase, AI systems and...
Nick Inboden
May 23, 20244 min read


Unveiling the Intersection of Biotech, Medicine, and Digital Marketing
Welcome to BioBeacon, a source for the latest news, updates, and in-depth information on biotechnology and medicine. Whether you're a...
Nick Inboden
May 21, 20242 min read
bottom of page